Sentinel lymph node biopsy: Authors' reply

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7458.170-c (Published 15 July 2004) Cite this as: BMJ 2004;329:170
  1. Malcolm R Kell (malcolmkell@eircom.net), senior specialist registrar,
  2. Michael J Kerin, consultant surgeon
  1. Department of Surgery, National Breast Cancer Screening Programme, Eccles Unit, Mater Misericordiae Hospital, Dublin 7, Republic of Ireland

    EDITOR—As we said, numerous issues about sentinel lymph node biopsy will be answered only by prospective clinical trials. The technique is a very important minimally invasive predictive prognostic indicator in breast cancer and melanoma. In these conditions performing either no lymphatic surgery or lymphatic clearance surgery on all patients would be neither evidence based nor …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription